HCmed Innovations Co., Ltd., in collaboration with one of the world's top 10 pharmaceutical companies, has officially launched its vibrating mesh nebulizer, Deepro, in the Federative Republic of Brazil.
HCmed Innovations (HCmed) confirmed on December 27, 2017, that Vivo capital, through the fund under its management, PANDA Fund, L.P., has become its strategic investor.
Nebulization is a time-tested approach for delivering aerosol to targeted pulmonary areas, especially for inhalation therapies that require deep lung deposition.
The principle of nebulizer therapy can be tracked as far back as 4000 years ago. Since the earliest days of recorded human history, people have been suffering from throat and chest pains.